Scleroderma dramatically under-diagnosed with commercial screening method, study suggests
Sunday, November 7, 2010 - 21:30
in Health & Medicine
New research suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test.